Centre for Heart Lung Innovation, University of British Columbia, Vancouver, BC, Canada.
J Intern Med. 2017 May;281(5):518-529. doi: 10.1111/joim.12601. Epub 2017 Mar 19.
Sepsis is associated with decreased levels of high-density lipoprotein (HDL) cholesterol. HDL has anti-inflammatory properties, and the use of Apo A-I mimetic peptides is associated with renal function improvement in animal models of sepsis. However, it is not known whether decreased HDL level results in impaired renal function in human sepsis. We investigated whether low levels of HDL conferred an increased risk of sepsis-associated acute kidney injury (AKI) or long-term decreased estimated glomerular filtration rate (eGFR) after sepsis.
HDL concentration (mg dL ) was measured in plasma samples from 180 patients with septic shock at admission to the Emergency Department (ED). We divided the patients using median HDL as a cut-off value and assessed the frequency of sepsis-associated AKI and long-term decreased eGFR after sepsis. Univariate and multivariate analyses were performed.
Patients with low HDL had a significantly greater frequency of KDIGO 2 or 3 sepsis-associated AKI [39/90 (43.3%) vs. 12/90 (13.3%), P < 0.001] and decreased long-term eGFR [24/58 (41.4%) vs. 11/57 (19.3%), P = 0.018] compared to those with high HDL. The adjusted OR for sepsis-associated AKI and decreased eGFR after sepsis in the lower HDL group was 2.80 (95% CI 1.08-7.25, P = 0.033) and 5.45 (95% CI 1.57-18.93, P = 0.008), respectively.
Low HDL levels during sepsis are associated with increased risk of sepsis-associated AKI, and/or subsequent decreased eGFR. These results suggest that HDL may be involved and/or may be a marker of kidney injury during and after sepsis.
脓毒症与高密度脂蛋白(HDL)胆固醇水平降低有关。HDL 具有抗炎作用,在脓毒症动物模型中使用载脂蛋白 A-I 模拟肽与肾功能改善相关。然而,在人类脓毒症中,HDL 水平降低是否导致肾功能受损尚不清楚。我们研究了 HDL 水平降低是否会增加脓毒症相关急性肾损伤(AKI)的风险,或者在脓毒症后是否会长期降低估算肾小球滤过率(eGFR)。
在急诊科(ED)入院时测量了 180 例脓毒性休克患者的血浆样本中的 HDL 浓度(mg/dL)。我们以中位数 HDL 为界值将患者分为两组,并评估了脓毒症相关 AKI 和脓毒症后长期 eGFR 降低的频率。进行了单变量和多变量分析。
低 HDL 组患者发生 KDIGO 2 或 3 级脓毒症相关 AKI 的频率显著更高[39/90(43.3%)比 12/90(13.3%),P<0.001],长期 eGFR 降低的频率也更高[24/58(41.4%)比 11/57(19.3%),P=0.018]。在低 HDL 组中,脓毒症相关 AKI 和脓毒症后 eGFR 降低的调整 OR 分别为 2.80(95%CI 1.08-7.25,P=0.033)和 5.45(95%CI 1.57-18.93,P=0.008)。
脓毒症期间的低 HDL 水平与脓毒症相关 AKI 的风险增加有关,和/或随后 eGFR 降低。这些结果表明,HDL 可能在脓毒症期间和之后的肾损伤中发挥作用和/或可能是肾损伤的标志物。